-
1
-
-
79953794760
-
Blood aging, safety, and transfusion: capturing the "radical" menace
-
Buehler P.W., et al. Blood aging, safety, and transfusion: capturing the "radical" menace. Antioxid. Redox Signal. 2011, 14:1713-1738.
-
(2011)
Antioxid. Redox Signal.
, vol.14
, pp. 1713-1738
-
-
Buehler, P.W.1
-
2
-
-
1242353138
-
Oxygen therapeutics: can we tame haemoglobin?
-
Alayash A.I. Oxygen therapeutics: can we tame haemoglobin?. Nat. Rev. Drug Discov. 2004, 3:152-159.
-
(2004)
Nat. Rev. Drug Discov.
, vol.3
, pp. 152-159
-
-
Alayash, A.I.1
-
3
-
-
70350441470
-
Hemoglobin-based oxygen carriers: current status and future directions
-
Silverman T.A., Weiskopf R.B. Hemoglobin-based oxygen carriers: current status and future directions. Anesthesiology 2009, 111:946-963.
-
(2009)
Anesthesiology
, vol.111
, pp. 946-963
-
-
Silverman, T.A.1
Weiskopf, R.B.2
-
4
-
-
33947494971
-
Structural basis of peroxide-mediated changes in human hemoglobin: a novel oxidative pathway
-
Jia Y., et al. Structural basis of peroxide-mediated changes in human hemoglobin: a novel oxidative pathway. J. Biol. Chem. 2007, 282:4894-4907.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 4894-4907
-
-
Jia, Y.1
-
5
-
-
34548842263
-
Effects of endogenous ascorbate on oxidation, oxygenation and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig
-
Buehler P.W., et al. Effects of endogenous ascorbate on oxidation, oxygenation and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig. J. Pharm. Exp. Ther. 2007, 323:49-60.
-
(2007)
J. Pharm. Exp. Ther.
, vol.323
, pp. 49-60
-
-
Buehler, P.W.1
-
6
-
-
79952763426
-
Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin
-
Butt O.I. Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin. Am. J. Pathol. 2011, 178:1316-1328.
-
(2011)
Am. J. Pathol.
, vol.178
, pp. 1316-1328
-
-
Butt, O.I.1
-
7
-
-
84871708157
-
Haptoglobin binding stabilizes hemoglobin ferryl iron and globin radical on Tyrosine β-145
-
(in press)
-
Cooper, E.C. et al. Haptoglobin binding stabilizes hemoglobin ferryl iron and globin radical on Tyrosine β-145. Antioxid. Redox Signal. (in press).
-
Antioxid. Redox Signal.
-
-
Cooper, E.C.1
-
8
-
-
84865325486
-
Haptoglobin alters oxygenation and oxidation of hemoglobin and decreases propagation of peroxide-induced oxidative reactions
-
Banerjee S., et al. Haptoglobin alters oxygenation and oxidation of hemoglobin and decreases propagation of peroxide-induced oxidative reactions. Free Radic. Biol. Med. 2012, 53:1317-1326.
-
(2012)
Free Radic. Biol. Med.
, vol.53
, pp. 1317-1326
-
-
Banerjee, S.1
-
9
-
-
84866504266
-
Structure of the haptoglobin-haemoglobin complex
-
Andersen C.B., et al. Structure of the haptoglobin-haemoglobin complex. Nature 2012, 489:456-459.
-
(2012)
Nature
, vol.489
, pp. 456-459
-
-
Andersen, C.B.1
-
10
-
-
84871704284
-
Molecular modeling of the human hemoglobin-haptoglobin complex shed light on the protective mechanisms of haptoglobin
-
(in press)
-
Natasenamat, C. et al. Molecular modeling of the human hemoglobin-haptoglobin complex shed light on the protective mechanisms of haptoglobin. PLoS ONE (in press).
-
PLoS ONE
-
-
Natasenamat, C.1
-
11
-
-
33847749415
-
A unique loop extension of the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex
-
Nielson M.J., et al. A unique loop extension of the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J. Biol. Chem. 2007, 282:1072-1079.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 1072-1079
-
-
Nielson, M.J.1
-
12
-
-
84859712543
-
Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy
-
Baek J.H., et al. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J. Clin. Invest. 2012, 122:1444-1458.
-
(2012)
J. Clin. Invest.
, vol.122
, pp. 1444-1458
-
-
Baek, J.H.1
|